180 related articles for article (PubMed ID: 20440681)
21. Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells.
Rahman MM; Bagdassarian E; Ali MAM; McFadden G
Sci Rep; 2017 Nov; 7(1):15710. PubMed ID: 29146961
[TBL] [Abstract][Full Text] [Related]
22. Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.
Zemp FJ; McKenzie BA; Lun X; Maxwell L; Reilly KM; McFadden G; Yong VW; Forsyth PA
PLoS One; 2013; 8(6):e65801. PubMed ID: 23762429
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic Virotherapy with Myxoma Virus.
Rahman MM; McFadden G
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936317
[TBL] [Abstract][Full Text] [Related]
24. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL
Viruses; 2020 May; 12(5):. PubMed ID: 32397134
[TBL] [Abstract][Full Text] [Related]
25. Myxoma virus in the European rabbit: interactions between the virus and its susceptible host.
Stanford MM; Werden SJ; McFadden G
Vet Res; 2007; 38(2):299-318. PubMed ID: 17296158
[TBL] [Abstract][Full Text] [Related]
26. The complete DNA sequence of myxoma virus.
Cameron C; Hota-Mitchell S; Chen L; Barrett J; Cao JX; Macaulay C; Willer D; Evans D; McFadden G
Virology; 1999 Nov; 264(2):298-318. PubMed ID: 10562494
[TBL] [Abstract][Full Text] [Related]
27. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression.
Boutard B; Vankerckhove S; Markine-Goriaynoff N; Sarlet M; Desmecht D; McFadden G; Vanderplasschen A; Gillet L
PLoS One; 2015; 10(2):e0118806. PubMed ID: 25705900
[TBL] [Abstract][Full Text] [Related]
28. Reverse Engineering Field Isolates of Myxoma Virus Demonstrates that Some Gene Disruptions or Losses of Function Do Not Explain Virulence Changes Observed in the Field.
Liu J; Cattadori IM; Sim DG; Eden JS; Holmes EC; Read AF; Kerr PJ
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768866
[TBL] [Abstract][Full Text] [Related]
29. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
[TBL] [Abstract][Full Text] [Related]
30. Characterization and functional analysis of Serp3: a novel myxoma virus-encoded serpin involved in virulence.
Guerin JL; Gelfi J; Camus C; Delverdier M; Whisstock JC; Amardeihl MF; Py R; Bertagnoli S; Messud-Petit F
J Gen Virol; 2001 Jun; 82(Pt 6):1407-1417. PubMed ID: 11369885
[TBL] [Abstract][Full Text] [Related]
31. The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.
Liu J; Wennier S; McFadden G
Microbes Infect; 2010 Dec; 12(14-15):1144-52. PubMed ID: 20832500
[TBL] [Abstract][Full Text] [Related]
32. MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection.
Blanié S; Gelfi J; Bertagnoli S; Camus-Bouclainville C
Virol J; 2010 Mar; 7():56. PubMed ID: 20211013
[TBL] [Abstract][Full Text] [Related]
33. Next step in the ongoing arms race between myxoma virus and wild rabbits in Australia is a novel disease phenotype.
Kerr PJ; Cattadori IM; Liu J; Sim DG; Dodds JW; Brooks JW; Kennett MJ; Holmes EC; Read AF
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):9397-9402. PubMed ID: 28808019
[TBL] [Abstract][Full Text] [Related]
34. Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.
Kerr PJ; Eden JS; Di Giallonardo F; Peacock D; Liu J; Strive T; Read AF; Holmes EC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728252
[TBL] [Abstract][Full Text] [Related]
35. Studies in the epidemiology of myxomatosis in California. IV. The susceptibility of six leporid species to Californian myxoma virus and the relative infectivity of their tumors for mosquitoes.
Regnery DC; Marshall ID
Am J Epidemiol; 1971 Nov; 94(5):508-13. PubMed ID: 5166039
[No Abstract] [Full Text] [Related]
36. Myxomatosis in Australia and Europe: a model for emerging infectious diseases.
Kerr PJ
Antiviral Res; 2012 Mar; 93(3):387-415. PubMed ID: 22333483
[TBL] [Abstract][Full Text] [Related]
37. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes.
Macen JL; Graham KA; Lee SF; Schreiber M; Boshkov LK; McFadden G
Virology; 1996 Apr; 218(1):232-7. PubMed ID: 8615027
[TBL] [Abstract][Full Text] [Related]
38. Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virus.
Weng M; Zhang M; Qin Y; Gong W; Tang Z; Quan Z; Wu K
Chin Med J (Engl); 2014; 127(12):2350-6. PubMed ID: 24931255
[TBL] [Abstract][Full Text] [Related]
39. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation.
Macen JL; Upton C; Nation N; McFadden G
Virology; 1993 Aug; 195(2):348-63. PubMed ID: 8337817
[TBL] [Abstract][Full Text] [Related]
40. Host-specificity of myxoma virus: Pathogenesis of South American and North American strains of myxoma virus in two North American lagomorph species.
Silvers L; Barnard D; Knowlton F; Inglis B; Labudovic A; Holland MK; Janssens PA; van Leeuwen BH; Kerr PJ
Vet Microbiol; 2010 Mar; 141(3-4):289-300. PubMed ID: 19836172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
